Corcept Therapeutics Incorporated (LON:0I3Q)
64.94
-4.72 (-6.77%)
Feb 21, 2025, 4:33 PM BST
Corcept Therapeutics Employees
Corcept Therapeutics had 352 employees as of December 31, 2023. The number of employees increased by 53 or 17.73% compared to the previous year.
Employees
352
Change (1Y)
53
Growth (1Y)
17.73%
Revenue / Employee
1.33M GBP
Profits / Employee
297.78K GBP
Market Cap
5.27B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 89,900 |
GSK plc | 70,212 |
Haleon | 25,408 |
Smith & Nephew | 18,452 |
Hikma Pharmaceuticals | 9,100 |
ConvaTec Group | 10,136 |
HUTCHMED (China) | 1,988 |
Oxford Nanopore Technologies | 1,238 |
Corcept Therapeutics News
- 10 days ago - Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2024 Financial Results, Provide Corporate Update and Host Conference Call - Business Wire
- 25 days ago - Big Money Keeps Buying Corcept - FX Empire
- 4 weeks ago - Kuehn Law Encourages Investors of Corcept Therapeutics Inc. to Contact Law Firm - PRNewsWire
- 4 weeks ago - Corcept Therapeutics Generating Strong Revenue And Profit Growth - Seeking Alpha
- 4 weeks ago - Medical Stock Soars To Highs As Cortisol Screening Grows - Investor's Business Daily
- 7 weeks ago - Corcept Submits New Drug Application for Relacorilant as a Treatment for Patients With Hypercortisolism - Business Wire
- 2 months ago - Corcept Therapeutics Inc (CORT) Announces Promising Phase 3 Study Results for Relacorilant - GuruFocus
- 2 months ago - Corcept's Phase 3 Long-Term Extension Study of Relacorilant Demonstrated Durable Cardiometabolic Improvements in Patients with Hypercortisolism - Business Wire